Lidbrink E, Frisell J, Brandberg Y, Rosendahl I, Rutqvist L E
Department of Oncology, Söder Hospital, Stockholm, Sweden.
Breast Cancer Res Treat. 1995 Sep;35(3):267-75. doi: 10.1007/BF00665978.
The first objective of this study was to analyze the survival rate in a group of 69 breast cancers detected among nonattenders in a randomized mammographic screening trial in relation to 142 clinically detected cancers in a nonscreened control population. By analyzing the cancers of the nonattenders we identified two subgroups, one (A) had actively avoided mammography, had cancers in more advanced stages on diagnosis, and had significantly higher mortality from breast cancer than the control group (p = 0.003). The second subgroup (B) had mammography done outside the screening program. This subgroup had a nonsignificant, slightly better survival (p = 0.19) compared to the control group. Concerning stage the cancers in group B were similar to the cancers by the screening program. The second objective was to analyze women's reasons for nonattendance in the screening program. We interviewed 200 randomly selected nonattenders; 33% stated that they never could imaging having mammography (definite nonattenders), 29.5% that they for various reasons had missed the mammography but could imagine having it next time (possible future attenders), and 32% had been examined outside the program. Reasons for nonattendance included disinterest, medical problems, and fear of X-rays. From this interview investigation we believe that the subgroup of definite nonattenders (33%) is difficult to influence. The second subgroup classified as possible future attenders (29.5%) we believe can be influenced by more information and a new opportunity to receive mammography, i.e., a reminder letter. The third subgroup, those examined outside the screening program (32%) were aware of the benefit of mammography, taking action on their own.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究的首要目标是,分析在一项随机乳腺钼靶筛查试验中未参加者群体里检测出的69例乳腺癌的生存率,并与未筛查的对照人群中临床检测出的142例癌症进行对比。通过分析未参加者的癌症情况,我们识别出两个亚组,其中一个亚组(A)主动回避乳腺钼靶检查,诊断时癌症处于更晚期阶段,乳腺癌死亡率显著高于对照组(p = 0.003)。第二个亚组(B)在筛查项目之外进行了乳腺钼靶检查。与对照组相比,该亚组生存率虽无显著差异,但略高(p = 0.19)。就分期而言,B组的癌症与筛查项目中的癌症相似。第二个目标是分析女性不参加筛查项目的原因。我们随机采访了200名未参加者;33%表示她们根本无法想象自己会进行乳腺钼靶检查(明确的未参加者),29.5%称她们因各种原因错过了乳腺钼靶检查,但下次可以想象会去做(可能未来会参加者),32%在项目之外接受过检查。不参加的原因包括不感兴趣、医疗问题以及对X射线的恐惧。通过这次访谈调查,我们认为明确的未参加者亚组(33%)很难被影响。我们认为第二个被归类为可能未来会参加者的亚组(29.5%)可以通过更多信息以及接受乳腺钼靶检查的新机会,即提醒信,来加以影响。第三个亚组,即在筛查项目之外接受检查的那些人(32%)了解乳腺钼靶检查的益处,并自行采取了行动。(摘要截选至250词)